Skip to main content
. 2021 Mar 5;2:1–8. doi: 10.1016/j.urine.2021.02.001

Fig. 2.

Fig. 2

Identification and quantification of urine samples from COVID-19 patients and healthy controls. (A&B&C) The accumulation curve of the quantified proteins from 32 healthy volunteers (A), 6 COVID-19 patients (B) and 2 recovery patients (C). (D) The Venn diagram for the identified urine proteins from the healthy volunteers, COVID-19 and recovery patients. (E) The dynamic range of the iBAQ abundance of identified proteins from healthy volunteers, COVID-19 patients and recovery ones. The average abundance for each group was calculated.